middle.news
Acrux CEO Michael Kotsanis to Retire After Driving Decade of Growth
5:21pm on Sunday 1st of June, 2025 AEST
•
Pharmaceuticals
Read Story
Acrux CEO Michael Kotsanis to Retire After Driving Decade of Growth
5:21pm on Sunday 1st of June, 2025 AEST
Key Points
Michael Kotsanis retiring after over a decade as Acrux CEO
CEO transition planned with orderly handover to successor
Kotsanis credited with developing successful generic drug strategy
Company progressing multiple FDA filings to expand product portfolio
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Acrux (ASX:ACR)
OPEN ARTICLE